Tag Archives: CEOs
By Ben Comer | Published: September 11, 2013
Already approved in 22 countries, GW Pharma’s Sativex product, if approved by FDA, would become the first prescription drug derived from raw cannabis to enter the US market. In the last several years, the US – a place where marijuana still has a decidedly bad reputation, and a prosecutorial history tinged with socioeconomic bias, if [...]
By Ben Comer | Published: June 11, 2012
Following his keynote address last week at the Financial Times US Healthcare and Life Sciences Conference in New York, Eli Lilly CEO John Lechleiter huddled into a corridor to speak with PharmExec about his agenda as incoming chairman of PhRMA, and how to fix innovation.
By Ben Comer | Published: February 3, 2012
Allergan CEO David Pyott is bullish on Botox’s potential as a salve for chronic migraine. He’s also betting on a next-gen dihydroergotamine (DHE) – Levadex – from MAP Pharmaceuticals.
By Ben Comer | Published: October 11, 2011
The role of the pharmacist in positive health outcomes – and drug company profits – is often cited in discussions around adherence to medication regimens, holistic prescribing practices and the navigation of insurance payment structures. In an attempt to demystify that role, Medco CEO David Snow told attendees at the Cleveland Clinic’s Medical Innovation Summit last [...]
By Julian Upton | Published: August 17, 2009
Far be it from me to politicize this blog, but I have great trouble understanding how anyone can brand a system based on the principles of providing healthcare for all as â€˜evil’.Â The UK NHS has many flaws. It is over-stretched, weary, beleaguered, underfunded, occasionally incompetent, occasionally misguided, in parts outmoded, over-managed and often frustrating. But [...]